Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Lessin

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Clinical and Diagnostic Laboratory Immunology|January 5, 1999
Quantitative analysis of T-cell receptor beta variable-gene usage in cutaneous late-phase reactions: implications for T-lymphocyte recruitment in cutaneous inflammationS R Lessin, B M Benoit, G Li, et al.
Artificial Organs|December 1, 1994
Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejectionJ T Wolfe, S R Lessin, A H Singh, et al.
Journal of Cutaneous Pathology|August 1, 1996
Correlation between clonotypic T-cell receptor beta chain variable region (TCR-V beta) gene expression and aberrant T-cell antigen expression in cutaneous T-cell lymphomaD T Finn, C Jaworsky, L Chooback, et al.
Cytokine|July 6, 2000
Quantitative comparison of cytokine mRNA and inflammatory responses in cutaneous late phase allergic reactionsB Zweiman, C M Parrott, Y Graif, et al.
Dermatologic Clinics|April 1, 1993
Therapeutic applications of photopheresisA H Rook, J H Cohen, S R Lessin, et al.
The Journal of Investigative Dermatology|December 1, 1988
Chromosomal mapping of human keratin genes: evidence of non-linkageS R Lessin, K Huebner, M Isobe, et al.
Archives of Dermatology|October 1, 1991
Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observationsA H Rook, M B Prystowsky, M Cassin, et al.
The Journal of Investigative Dermatology|September 1, 1996
Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphomaG Li, B R Vowels, B M Benoit, et al.
Journal of the American Academy of Dermatology|May 1, 1995
De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphomaJ T Wolfe, A Singh, S R Lessin, et al.
Archives of Dermatology|December 1, 1990
Regressing atypical histiocytosis. Aberrant prothymocyte differentiation, T-cell receptor gene rearrangements, and nodal involvementC Jaworsky, V Cirillo-Hyland, J W Petrozzi, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Clinical and Diagnostic Laboratory Immunology|January 5, 1999
Quantitative analysis of T-cell receptor beta variable-gene usage in cutaneous late-phase reactions: implications for T-lymphocyte recruitment in cutaneous inflammationS R Lessin, B M Benoit, G Li, et al.
Artificial Organs|December 1, 1994
Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejectionJ T Wolfe, S R Lessin, A H Singh, et al.
Journal of Cutaneous Pathology|August 1, 1996
Correlation between clonotypic T-cell receptor beta chain variable region (TCR-V beta) gene expression and aberrant T-cell antigen expression in cutaneous T-cell lymphomaD T Finn, C Jaworsky, L Chooback, et al.
Cytokine|July 6, 2000
Quantitative comparison of cytokine mRNA and inflammatory responses in cutaneous late phase allergic reactionsB Zweiman, C M Parrott, Y Graif, et al.
Dermatologic Clinics|April 1, 1993
Therapeutic applications of photopheresisA H Rook, J H Cohen, S R Lessin, et al.
The Journal of Investigative Dermatology|December 1, 1988
Chromosomal mapping of human keratin genes: evidence of non-linkageS R Lessin, K Huebner, M Isobe, et al.
Archives of Dermatology|October 1, 1991
Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observationsA H Rook, M B Prystowsky, M Cassin, et al.
The Journal of Investigative Dermatology|September 1, 1996
Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphomaG Li, B R Vowels, B M Benoit, et al.
Journal of the American Academy of Dermatology|May 1, 1995
De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphomaJ T Wolfe, A Singh, S R Lessin, et al.
Archives of Dermatology|December 1, 1990
Regressing atypical histiocytosis. Aberrant prothymocyte differentiation, T-cell receptor gene rearrangements, and nodal involvementC Jaworsky, V Cirillo-Hyland, J W Petrozzi, et al.
Pageof 5